Favorable effects of intravenous beta blockers in ST elevation myocardial infarct: time for a revival?

J Cardiovasc Med (Hagerstown). 2018 Feb:19 Suppl 1:e26-e30. doi: 10.2459/JCM.0000000000000553.
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Intravenous
  • Adrenergic beta-Antagonists / administration & dosage*
  • Adrenergic beta-Antagonists / adverse effects
  • Animals
  • Drug Administration Schedule
  • Humans
  • Recovery of Function
  • Risk Factors
  • ST Elevation Myocardial Infarction / diagnosis
  • ST Elevation Myocardial Infarction / drug therapy*
  • ST Elevation Myocardial Infarction / mortality
  • ST Elevation Myocardial Infarction / physiopathology
  • Time Factors
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists